These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10908120)

  • 1. Novel cephalosporins 1. Synthesis of 3-benzothiopyranylthiovinyl cephalosporins and antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis.
    Yamazaki H; Tsuchida Y; Satoh H; Kawashima S; Hanaki H; Hiramatsu K
    J Antibiot (Tokyo); 2000 May; 53(5):546-50. PubMed ID: 10908120
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel cephalosporins 2. Synthesis of 3-heterocyclic-fused thiopyranylthiovinyl cephalosporins and antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis.
    Yamazaki H; Tsuchida Y; Satoh H; Kawashima S; Hanaki H; Hiramatsu K
    J Antibiot (Tokyo); 2000 May; 53(5):551-5. PubMed ID: 10908121
    [No Abstract]   [Full Text] [Related]  

  • 3. Structure-activity relationships of cephalosporin derivatives against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.
    Hanaki H; Akagi H; Nomura S; Unemi N; Hiramatsu K
    J Antibiot (Tokyo); 1996 Apr; 49(4):402-4. PubMed ID: 8642007
    [No Abstract]   [Full Text] [Related]  

  • 4. The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus.
    Seibert G; Isert D; Klesel N; Limbert M; Markus A; Schrinner E
    J Antimicrob Chemother; 1992 Apr; 29 Suppl A():25-30. PubMed ID: 1601753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 3: 7beta-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureido]-1-pyridinium at C-3'.
    Yoshizawa H; Kubota T; Itani H; Minami K; Miwa H; Nishitani Y
    Bioorg Med Chem; 2004 Aug; 12(15):4221-31. PubMed ID: 15246098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of chlorhexidine and povidone iodine activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis using a surface test.
    Block C; Robenshtok E; Simhon A; Shapiro M
    J Hosp Infect; 2000 Oct; 46(2):147-52. PubMed ID: 11049709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro and in-vivo activity of cefpirome (HR 810) against methicillin-susceptible and -resistant Staphylococcus aureus and Streptococcus faecalis.
    Eng RH; Cherubin CE; Smith SM; Buccini F; Harris R
    J Antimicrob Chemother; 1989 Mar; 23(3):373-81. PubMed ID: 2499565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 2: Synthesis and structure-activity relationships in the S-3578 series.
    Yoshizawa H; Kubota T; Itani H; Ishitobi H; Miwa H; Nishitani Y
    Bioorg Med Chem; 2004 Aug; 12(15):4211-9. PubMed ID: 15246097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-3578, a new broad spectrum parenteral cephalosporin exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Synthesis and structure-activity relationships.
    Yoshizawa H; Itani H; Ishikura K; Irie T; Yokoo K; Kubota T; Minami K; Iwaki T; Miwa H; Nishitani Y
    J Antibiot (Tokyo); 2002 Nov; 55(11):975-92. PubMed ID: 12546419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antibacterial activity of TOC-50, a new parenteral cephalosporin against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Nomura S; Hanaki H; Unemi N
    Chemotherapy; 1996; 42(4):253-8. PubMed ID: 8804792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel cephalosporins. Modification of the C-4 carboxyl group.
    Jen T; Dienel B; Frazee J; Weisbach J
    J Med Chem; 1972 Nov; 15(11):1172-4. PubMed ID: 4631921
    [No Abstract]   [Full Text] [Related]  

  • 12. Structure-activity relationships of 2-thioisocephem against methicillin-resistant Staphylococcus aureus.
    Hanaki H; Akagi H; Yasui M; Otani T
    J Antibiot (Tokyo); 1995 Aug; 48(8):901-3. PubMed ID: 7592041
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on anti-MRSA parenteral cephalosporins. II. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4- thiadiazol-3-yl)-2(Z)-alkoxyiminoacetamido]-3-(substituted imidaz.
    Ishikawa T; Kamiyama K; Matsunaga N; Tawada H; Iizawa Y; Okonogi K; Miyake A
    J Antibiot (Tokyo); 2000 Oct; 53(10):1071-85. PubMed ID: 11132951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel tetrahydro-thieno pyridyl oxazolidinone: an antibacterial agent.
    Lohray BB; Lohray VB; Srivastava BK; Kapadnis PB; Pandya P
    Bioorg Med Chem; 2004 Sep; 12(17):4557-64. PubMed ID: 15358283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of daptomycin against isolates of Staphylococcus aureus and enterococci: first results from Turkey.
    Arslan H; Azap OK; Ergin F; Karaman SO; Oruç E
    Int J Antimicrob Agents; 2004 Jun; 23(6):642-3. PubMed ID: 15194140
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro activity of tigecycline against quinolone-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
    Garrison MW; Nuemiller JJ
    Int J Antimicrob Agents; 2007 Feb; 29(2):191-6. PubMed ID: 17174074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymicrobial endocarditis caused by methicillin-resistant Staphylococcus aureus and glycopeptide-resistant enterococci.
    Bishara J; Sagie A; Samra Z; Pitlik S
    Eur J Clin Microbiol Infect Dis; 1999 Sep; 18(9):674-5. PubMed ID: 10534195
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on anti-MRSA parenteral cephalosporins. III. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)-alkoxyiminoacetamido-3.
    Ishikawa T; Kamiyama K; Nakayama Y; Iizawa Y; Okonogi K; Miyake A
    J Antibiot (Tokyo); 2001 Mar; 54(3):257-77. PubMed ID: 11372783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-MRSA cephems. Part 1: C-3 substituted thiopyridinium derivatives.
    Springer DM; Luh BY; Bronson JJ
    Bioorg Med Chem Lett; 2001 Mar; 11(6):797-801. PubMed ID: 11277523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro synergy between cefepime and vancomycin against methicillin-susceptible and -resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Lozniewski A; Lion C; Mory F; Weber M
    J Antimicrob Chemother; 2001 Jan; 47(1):83-6. PubMed ID: 11152435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.